Exhibit 4.17
REGISTRATION RIGHTS AGREEMENT
This Registration Rights Agreement (this "AGREEMENT"), dated April 19,
2004 (the "AGREEMENT DATE"), is between ADVENTRX Pharmaceuticals, Inc., a
Delaware corporation (the "COMPANY") and Xxxxxxxx X. Xxxxxx (the "INVESTOR").
BACKGROUND
A. The Company and the Investor have entered into a Common Stock and
Warrant Purchase Agreement (the "PURCHASE AGREEMENT") as of the Agreement
Date pursuant to which the Company desires to sell to the Investor and the
Investor desires to purchase from the Company shares of Common Stock, par
value $0.001 per share ("COMMON STOCK"), of the Company (the "SHARES").
B. As additional consideration for the purchase of the Shares,
pursuant to the Purchase Agreement, the Company shall issue to the
Investor certain warrants to purchase shares of Common Stock (the
"WARRANTS").
C. A condition to the obligations under the Purchase Agreement is
that the Company and the Investor enter into this Agreement in order to
provide the Investor with certain rights to register the resale of the
Shares and the Warrant Shares (as defined herein).
AGREEMENT
In consideration of the mutual promises, representations, warranties,
covenants and conditions set forth in this Agreement, the parties agree as
follows:
1. DEFINITIONS. For purposes of this Agreement, the term:
(A) "REGISTRABLE SECURITIES" means (a) the Shares and the Warrant
Shares or other securities issued or issuable to the Investor or its
transferees, assignees or designee (i) upon exercise of the Warrants, or
(ii) upon any dividend or distribution with respect to, any exchange for
or any replacement of the Shares, Warrants or Warrant Shares or (iii) upon
any conversion, exercise or exchange of any securities issued in
connection with any such distribution, exchange or replacement; (b)
securities issued or issuable upon any stock split, stock dividend,
recapitalization or similar event with respect to the foregoing; (c)
securities issued pursuant to Section 8 of the Purchase Agreement, Section
9 or Section 10 of this Agreement or Section 3 of the Warrants and (d) any
other security issued as a dividend or other distribution with respect to,
in exchange for, in replacement or redemption of, or in reduction of the
liquidation value of, any of the securities referred to in the preceding
clauses. The parties acknowledge that the Company may choose to include
the Registrable Securities hereunder on a registration statement with
other similar securities.
(B) "INVESTOR" means collectively the Investor and any transferees,
assignees or designees thereof who hold Registrable Securities.
(C) "COMMISSION" means the Securities and Exchange Commission.
1
(D) "WARRANT SHARES" means the shares of Common Stock issuable upon
exercise of the Warrants.
(E) "SECURITIES ACT" means the Securities Act of 1933, as amended.
(F) "EXCHANGE ACT" means the Exchange Act of 1934, as amended.
2. FILING OF REGISTRATION STATEMENT.
(A) The Company shall prepare and file with the Commission a "shelf"
registration statement (a "REGISTRATION STATEMENT") on Form S-3 (or if
such form is not available to the Company on another form appropriate for
such registration in accordance herewith) covering all Registrable
Securities for a secondary or resale offering to be made on a continuous
basis pursuant to Rule 415, such Registration Statement to be filed by no
later than June 30, 2004 (the "TARGET FILING DATE"). The Company shall use
its best efforts to cause the Registration Statement to be declared
effective under the Securities Act not later than 90 days after the Target
Filing Date (including filing with the Commission a request for
acceleration of effectiveness in accordance with Rule 461 promulgated
under the Securities Act within five business days of the date that the
Company is notified (orally or in writing, whichever is earlier) by the
Commission that a Registration Statement will not be "reviewed," or not be
subject to further review) and to keep such Registration Statement
continuously effective under the Securities Act until such date as is the
earlier of (x) the date when all Registrable Securities covered by such
Registration Statement have been sold or (y) the second anniversary of the
Agreement Date (the "EFFECTIVENESS PERIOD"). Upon the initial filing
thereof, the Registration Statement shall cover at least 100% of the
Shares and 100% of the Warrant Shares. Such Registration Statement also
shall cover, to the extent allowable under the Securities Act and the
rules promulgated thereunder (including Securities Act Rule 416), such
indeterminate number of additional shares of Common Stock resulting from
stock splits, stock dividends or similar transactions with respect to the
Registrable Securities. Not less than three business days prior to the
filing of the Registration Statement or any related prospectus or any
amendment or supplement thereto, the Company shall (i) furnish to the
Investor copies of all such documents proposed to be filed, which
documents (other than those incorporated by reference) and (ii) at the
request of the Investor of Registrable Securities cause its officers and
directors, counsel and independent certified public accountants to respond
to such inquiries as shall be reasonably necessary, in the reasonable
opinion of the Investor, to conduct a reasonable investigation within the
meaning of the Securities Act. The Company shall not file the Registration
Statement or any such prospectus or any amendments or supplements thereto
to which the Investor shall reasonably object in writing within three
business days after their receipt thereof.
(B) The Company shall (i) prepare and file with the Commission such
amendments, including post-effective amendments, to the Registration
Statement as may be necessary to keep the Registration Statement
continuously effective as to all Registrable Securities for the
Effectiveness Period and to the extent any Registrable Securities are not
included in such Registration Statement for reasons other than the failure
of the Investor to comply with Section 4 hereof,
2
shall prepare and file with the Commission such additional Registration
Statements in order to register for resale under the Securities Act all
Registrable Securities; (ii) cause the related prospectus to be amended or
supplemented by any required prospectus supplement, and as so supplemented or
amended to be filed pursuant to Rule 424 (or any similar provisions then in
force) promulgated under the Securities Act; (iii) respond as promptly as
possible, and in no event later than 10 business days, to any comments received
from the Commission with respect to the Registration Statement or any amendment
thereto and as promptly as possible, upon request, provide the Investor true and
complete copies of all correspondence from and to the Commission relating to the
Registration Statement; and (iv) comply in all material respects with the
provisions of the Securities Act and the Exchange Act with respect to the
disposition of all Registrable Securities covered by the Registration Statement
during the applicable period in accordance with the intended methods of
disposition by the Investor thereof set forth in the Registration Statement as
so amended or in such prospectus as so supplemented.
(C) The Company shall notify the Investor as promptly as possible
(i) when a prospectus or any prospectus supplement or post-effective
amendment to the Registration Statement is proposed to be filed (but in no
event in the case of this subparagraph (i), less than three business days
prior to the date of such filing); (ii) when the Commission notifies the
Company whether there will be a "review" of such Registration Statement;
and (iii) with respect to the Registration Statement or any post-effective
amendment, when the same has become effective, and after the effectiveness
thereof: (A) of any request by the Commission or any other Federal or
state governmental authority for amendments or supplements to the
Registration Statement or prospectus or for additional information; (B) of
the issuance by the Commission of any stop order suspending the
effectiveness of the Registration Statement covering any or all of the
Registrable Securities or the initiation of any proceedings for that
purpose; (C) of the receipt by the Company of any notification with
respect to the suspension of the qualification or exemption from
qualification of any of the Registrable Securities for sale in any
jurisdiction, or the initiation or threatening of any proceeding for such
purpose; and (D) if the financial statements included in the Registration
Statement become ineligible for inclusion therein or of the occurrence of
any event that makes any statement made in the Registration Statement or
prospectus or any document incorporated or deemed to be incorporated
therein by reference untrue in any material respect or that requires any
revisions to the Registration Statement, prospectus or other documents so
that, in the case of the Registration Statement or the prospectus, as the
case may be, it will not contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or
necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading. Without
limitation to any remedies to which the Investor may be entitled under
this Agreement, if any of the events described in Section 2(c)(iii) occur,
the Company shall use its best efforts to respond to and correct the
event.
(D) The Investor acknowledges that the Registration Statement shall
also register a significant amount of shares of Common Stock owned by
other stockholders which have "piggy-back" registration rights under
various agreements with the Company.
3
3. PIGGY-BACK REGISTRATION.
(A) RIGHT TO PIGGY-BACK. If (but without any obligation to do so
other than as provided above) the Company proposes to register any shares
of Common Stock in connection with any offering of shares of Common Stock
pursuant to a registration statement under the Securities Act (other than
a registration relating solely to the sale of securities to participants
in a Company stock plan or a transaction covered by Rule 145 under the
Securities Act, or a registration in which the only stock being registered
is Common Stock issuable upon conversion of debt securities which are also
being registered) (a "PUBLIC OFFERING"), the Company shall promptly give
the Investor written notice of such registration, at least 10 business
days prior to the filing of any registration statement under the
Securities Act. Upon the written request of the Investor given within 5
business days after delivery of such written notice by the Company, the
Company shall, subject to the provisions of Section 3(b) below, use its
best efforts to cause to be registered under the Securities Act on such
registration statement all of the Registrable Securities that the Investor
has requested to be registered.
(B) UNDERWRITING. If the registration statement under which the
Company gives notice under Section 3(a) is for an underwritten Public
Offering, the Company shall so advise the Investor. The right of the
Investor to registration pursuant to Section 3(a) above shall be
conditioned upon the Investor's participation in such underwriting and the
inclusion of the Registrable Securities in the underwriting to the extent
provided herein. The Investor shall (together with the Company and any
other holders of Company securities distributing their securities through
such underwriting) enter into an underwriting agreement in customary form
with the underwriter or underwriters selected for underwriting by the
Company. Notwithstanding any other provision of Sections 3(a), if the
underwriter determines that marketing factors require a limitation of the
number of shares to be underwritten, the underwriter may exclude some or
all of the Registrable Securities from such registration and underwriting.
4. FURNISH INFORMATION. It shall be a condition to the Company's
obligations to take any action under this Agreement with respect to the
Registrable Securities of the Investor that the Investor shall promptly furnish
to the Company, upon request, such information regarding itself, the Registrable
Securities, and the intended method of disposition of such securities as shall
be necessary to effect the registration of its Registrable Securities. In that
connection, the Investor shall be required to represent to the Company that all
such information which is given is both complete and accurate in all material
respects when made.
5. DELAY OF REGISTRATION. THE INVESTOR shall have no right to obtain or
seek an injunction restraining or otherwise delaying any such registration as
the result of any controversy that might arise with respect to the
interpretation or implementation of the terms of this Agreement.
6. TERMINATION OF REGISTRATION RIGHTS. Following the end of the
Effectiveness Period, the Company shall have no obligation to register the
Registrable Securities pursuant to this Agreement or otherwise.
4
7. INDEMNIFICATION.
(A) To the extent permitted by law, the Company shall,
notwithstanding any termination of this Agreement, indemnify and hold
harmless the Investor, to the fullest extent permitted by applicable law,
from and against any and all losses, claims, damages, liabilities, costs
(including, without limitation, costs of preparation and reasonable
attorneys' fees) and expenses (collectively, "LOSSES"), as incurred,
arising out of or relating to any untrue or alleged untrue statement of a
material fact contained or incorporated by reference in the Registration
Statement, any prospectus or any form of prospectus or in any amendment or
supplement thereto or in any preliminary prospectus, or arising out of or
relating to any omission or alleged omission of a material fact required
to be stated therein or necessary to make the statements therein (in the
case of any prospectus or form of prospectus or amendment or supplement
thereto, in the light of the circumstances under which they were made) not
misleading (collectively a "VIOLATION"), provided, however, that the
indemnity agreement contained in this Section 7(a) shall not apply to
amounts paid in settlement of any such Loss if such settlement is effected
without the prior written consent of the Company (which consent shall not
be unreasonably withheld), nor shall the Company be liable to the Investor
to the extent that any Loss arises out of or is based upon untrue
statements, omissions or violations which occur in reliance upon and in
conformity with information furnished expressly for use in connection with
such registration by the Investor.
(B) To the extent permitted by law, the Investor shall,
notwithstanding any termination of this Agreement, indemnify and hold
harmless the Company, each of its directors, each of its officers who has
signed the registration statement, each person, if any, who controls the
Company (within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act), any underwriter, any other stockholder of the
Company selling securities in such Registration Statement and any
controlling person of any such underwriter or other stockholder, against
any Losses, as incurred, arising out of or relating to any Violation in
each case to the extent (but only to the extent)that such Violation occurs
in reliance upon and in conformity with written information furnished in
writing expressly for use in connection with such registration by the
Investor; provided, however, that the indemnity agreement contained in
this Section 7(b) shall not apply to amounts paid in settlement of any
such Loss if such settlement is effected without the consent of the
Investor, which consent shall not be unreasonably withheld.
Notwithstanding anything to the contrary contained herein, the Investor
shall be liable in the aggregate under this Section 7(b) for only such
amounts, if any, as in the aggregate do not exceed the net proceeds to
such Investor as a result of the sale of Registrable Securities pursuant
to such Registration Statement.
5
8. LISTING. The Company shall cause all Registrable Securities to be
listed on any United States securities exchange, quotation system, market or
over-the-counter bulletin board on which similar securities issued by the
Company are then listed and use its best efforts to maintain such listing.
9. FAILURE TO FILE REGISTRATION STATEMENT. The Company and the Investor
agree that the Investor will suffer damages if the Registration Statement is not
filed on or prior to the Target Filing Date and maintained in the manner
contemplated herein during the Effectiveness Period. The Company and the
Investor further agree that it would not be feasible to ascertain the extent of
such damages with precision. Accordingly, if the Registration Statement is not
filed on or prior to the Target Filing Date, the Company shall pay in cash or in
shares of Common Stock (at the Company's option) as liquidated damages for such
failure and not as a penalty to the Investor an amount equal to two percent (2%)
of the purchase price the Investor paid for the Shares and Warrants purchased
pursuant to the Purchase Agreement (the "PURCHASE PRICE") for each 30-day period
until the Registration Statement has been filed with the Commission, which shall
be pro rated for such periods less than 30 days (the "LATE FILING DAMAGES").
Payments to be made to the Investor pursuant to this Section 9 shall be due and
payable within 5 business days of any demand therefor by the Investor, but in no
event more than once during any 30-day period. The parties agree that the Late
Filing Damages represent a reasonable estimate on the part of the parties, as of
the date of this Agreement, of the amount of damages that may be incurred by the
Investor if the Registration Statement is not filed on or prior to the Target
Filing Date. If the Company elects to pay the Late Filing Damages in shares of
Common Stock, such shares of Common Stock shall be valued at the average closing
price of a share of Common Stock on the applicable trading market for the Common
Stock for the 5-trading-day period immediately preceding the date of demand of
such Late Filing Damages.
10. FAILURE OF REGISTRATION STATEMENT TO BECOME EFFECTIVE. The Company and
the Investor agree that the Investor will suffer damages if the Registration
Statement is not declared effective by the Commission on or prior to the
ninetieth (90th) day following the Target Filing Date (the "EFFECTIVENESS
DEADLINE"). The Company and the Investor further agree that it would not be
feasible to ascertain the extent of such damages with precision. Accordingly, if
the Registration Statement is not declared effective by the Commission prior to
the Effectiveness Deadline, the Company shall pay in cash or in shares of Common
Stock (at the Company's option) as liquidated damages for such failure and not
as a penalty to the Investor an amount equal to (a) two percent (2%) of the
Purchase Price for the first 30-day period following the Effectiveness Deadline
(which shall be pro rated for such periods less than 30 days) and (b) one
percent (1%) of the Purchase Price for each subsequent 30-day period (which
shall be pro rated for such periods less than 30 days) (the "NON-EFFECTIVENESS
DAMAGES") until either (x) the Registration Statement is declared effective by
the Commission or (y) the first anniversary of the Agreement Date. Payments to
be made to the Investor pursuant to this Section 10 shall be due and payable
within 5 business days of any demand therefor by the Investor, but in no event
more than once during any 30-day period. The parties agree that the
Non-Effectiveness Damages represent a reasonable estimate on the part of the
parties, as of the Agreement Date, of the amount of damages that may be incurred
by the Investor if the Registration Statement is not declared effective on or
prior to the ninetieth (90th) day following the Target Filing Date. If the
Company elects to pay the Non-Effectiveness Damages in shares of Common Stock,
such shares of Common Stock shall be valued at the average closing price of a
share of Common Stock on the applicable trading market for the Common Stock for
the 5-trading-day period immediately preceding the date of demand of such
Non-Effectiveness Damages.
6
11. LISTING; EXCHANGE ACT REPORTS.
(A) The Company shall use commercially reasonable best efforts to
list its Common Stock on the American Stock Exchange.
(B) With a view to making available to the Investor the benefits of
Rule 144 promulgated under the Securities Act or any other similar rule or
regulation of the Commission that may at any time permit the Investor to
sell securities of the Company to the public without registration ("RULE
144"), the Company agrees to:
(I) make and keep public information available, as those terms are
understood and defined in Rule 144;
(II) file with the Commission in a timely manner all reports and other
documents required of the Company under the Securities Act and the
Securities Exchange Act of 1934, as amended (the "EXCHANGE ACT") so
long as the Company remains subject to such requirements and the
filing of such reports and other documents is required for the
applicable provisions of Rule 144; and
(III) furnish to the Investor so long as the Investor owns Registrable
Securities, promptly upon request, (i) a written statement by the
Company that it has complied with the reporting requirements of Rule
144, the Securities Act and the Exchange Act, (ii) a copy of the
most recent annual or quarterly report of the Company and such other
reports and documents so filed by the Company to the extent any such
report is not available on the Commission's website, and (iii) such
other information as may be reasonably requested to permit the
Investor to sell such securities pursuant to Rule 144 without
registration.
12. MISCELLANEOUS.
(A) GOVERNING LAW. This Agreement, all acts and transactions
pursuant hereto and the rights and obligations of the parties hereto shall
be governed, construed and interpreted in accordance with the laws of the
state of California, without giving effect to principles of choice of law.
(B) JURISDICTION AND VENUE. Any legal action or other legal
proceeding relating to this Agreement or the enforcement of any provision
of this Agreement shall be brought or otherwise commenced in any state or
federal court located in the county of San Diego, California. Each party
to this Agreement: (i) expressly and irrevocably consents and submits to
the jurisdiction of each state and federal court located in the county of
San Diego, California and each appellate court located in the state of
California, in connection with any such legal proceeding; (ii) agrees that
each state and federal court located in the county of San Diego,
California shall be deemed to be a convenient forum; and (iii) agrees not
to assert, by way of motion, as a defense or otherwise, in any such legal
proceeding commenced in any state or federal court located in the county
of San Diego, California any claim that such party is not subject
personally to the jurisdiction of such court, that such legal proceeding
has been brought in an inconvenient forum, that the venue of such
proceeding is improper or that this Agreement or the subject matter of
this Agreement may not be enforced in or by such court.
7
(C) ENTIRE AGREEMENT. This Agreement embodies the entire agreement
and understanding between the parties hereto with respect to the subject
matter hereof and supersedes all prior oral or written agreements and
understandings relating to the subject matter hereof. No statement,
representation, warranty, covenant or agreement of any kind not expressly
set forth in this Agreement shall affect, or be used to interpret, change
or restrict, the express terms and provisions of this Agreement.
(D) NOTICES. All notices and other communications hereunder shall be
in writing and shall be given (and shall be deemed to have been duly given
upon receipt) by delivery in person or facsimile transmission (received at
the facsimile machine to which it is transmitted prior to 5:00 p.m., local
time, on a business day in the state of California, for the party to which
it is sent), by courier or express delivery service or by registered or
certified mail (postage prepaid, return receipt requested) to the
respective parties at the following addresses (or at such other address
for a party as shall be specified in a notice given in accordance with
this Section):
if to the Company: ADVENTRX Pharmaceuticals, Inc.
0000 Xxxxxx Xxxxxx, Xxxxx 000
Xxx Xxxxx, XX 00000
Attention: Xxxxxxxx X. Xxxxx
Facsimile: (000) 000-0000
with a copy to (not to constitute notice): Xxxxxxx XxXxxxxxx LLP
0 Xxxxxxxxxxx Xxxxxx
Xxx Xxxxxxxxx, XX 00000-0000
Attention: Xxxxx X. Xxxxx, Xx.
Facsimile: (000) 000-0000
if to the Investor: Xxxxxxxx X. Xxxxxx
00 Xxxx 00xx Xxxxxx
Xxx Xxxx, XX 00000
Facsimile: (000) 000-0000
(E) AMENDMENTS AND WAIVERS. Any term of this Agreement may be
amended, waived or departed from only with the written consent of the
Company and the Investor. No such waiver or consent shall be deemed to be
or shall constitute a waiver or consent with respect to any other terms or
provisions of this Agreement, whether or not similar. Each such waiver or
consent shall be effective only in the specific instance and for the
purpose for which it was given, and shall not constitute a continuing
waiver or consent.
(F) SUCCESSORS AND ASSIGNS. This Agreement is personal to each of
the parties hereto and may not be assigned without the written consent of
the other party; provided, however, that the Investor shall be permitted
to assign this Agreement to any person to whom it assigns or transfers the
Warrants or Registrable Securities, other than in a public resale, in
compliance with applicable securities laws. Any assignee must be an
"accredited investor" as defined in Rule 501(a) promulgated under the
Securities Act.
8
(G) SEVERABILITY. In the event that any court of competent
jurisdiction shall determine that any provision, or any portion thereof,
contained in this Agreement shall be unenforceable in any respect, then
such provision shall be deemed limited to the extent that such court deems
it enforceable, and as so limited shall remain in full force and effect.
In the event that such court shall deem any such provision, or portion
thereof, wholly unenforceable, the remaining provisions of this Agreement
shall nevertheless remain in full force and effect.
(H) INTERPRETATION. The parties hereto acknowledge and agree that:
(i) each party and such party's counsel has reviewed the terms and
provisions of this Agreement; (ii) the rule of construction to the effect
that any ambiguities are resolved against the drafting party shall not be
employed in the interpretation of this Agreement; and (iii) the terms and
provisions of this Agreement shall be construed fairly as to the parties
hereto and not in favor of or against any party, regardless of which party
was generally responsible for the preparation of this Agreement. Whenever
used herein, the singular number shall include the plural, the plural
shall include the singular, the use of any gender shall include all
persons.
(I) HEADINGS AND CAPTIONS. The headings and captions of the various
subdivisions of this Agreement are for convenience of reference only and
shall in no way modify, or affect the meaning or construction of any of
the terms or provisions hereof.
(J) NO WAIVER OF RIGHTS, POWERS AND REMEDIES. No failure or delay by
a party hereto in exercising any right, power or remedy under this
Agreement, and no course of dealing between the parties hereto, shall
operate as a waiver of any such right, power or remedy of the party. No
single or partial exercise of any right, power or remedy under this
Agreement by a party hereto, nor any abandonment or discontinuance of
steps to enforce any such right, power or remedy, shall preclude such
party from any other or further exercise thereof or the exercise of any
other right, power or remedy hereunder. The election of any remedy by a
party hereto shall not constitute a waiver of the right of such party to
pursue other available remedies. No notice to or demand on a party not
expressly required under this Agreement shall entitle the party receiving
such notice or demand to any other or further notice or demand in similar
or other circumstances or constitute a waiver of the rights of the party
giving such notice or demand to any other or further action in any
circumstances without such notice or demand.
(K) REGISTRATION EXPENSES. All fees and expenses incident to the
performance of or compliance with this Agreement by the Company shall be
borne by the Company whether or not the Registration Statement is filed or
becomes effective and whether or not any Registrable Securities are sold
pursuant to the Registration Statement. The fees and expenses referred to
in the foregoing sentence shall include, without limitation, (i) all
registration and filing fees (including, without limitation, fees and
expenses (A) with respect to filings required to be made with the American
Stock Exchange and each other securities exchange, quotation system,
market or over-the-counter bulletin board on which Registrable Securities
are required hereunder to be listed, (B) with respect to filings required
to be made with the Commission, and (C) in compliance with state
securities or Blue Sky laws), (ii) printing expenses (including, without
limitation, expenses of printing certificates for Registrable Securities
and of printing or photocopying prospectuses), (iii) messenger, telephone
and delivery expenses, (iv) Securities Act liability insurance, if the
Company so desires such insurance, and (v) fees and expenses of all other
persons retained by the Company in connection with the consummation of the
9
transactions contemplated by this Agreement, including, without
limitation, the Company's independent public accountants (including, in
the case of an underwritten offering, the expenses of any comfort letters
or costs associated with the delivery by independent public accountants of
a comfort letter or comfort letters) and legal counsel. In addition, the
Company shall be responsible for all of its internal expenses incurred in
connection with the consummation of the transactions contemplated by this
Agreement (including, without limitation, all salaries and expenses of its
officers and employees performing legal or accounting duties), the expense
of any annual audit, and the fees and expenses incurred in connection with
the listing of the Registrable Securities on any securities exchange as
required hereunder.
(L) COUNTERPARTS AND FACSIMILE DELIVERY. This Agreement may be
executed in counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument. Any
signature page delivered by facsimile or other electronic image
transmission shall be binding to the same extent as an original signature
page, with regard to any agreement subject to the terms hereof or any
amendment thereto. Any party who delivers such a signature page agrees to
later deliver an original counterpart to any party who requests it.
[Signature page follows.]
10
SIGNATURE PAGE TO THE REGISTRATION RIGHTS AGREEMENT IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above
written.
ADVENTRX PHARMACEUTICALS, INC.
By: /s/ Xxxx X. Xxxxxx
----------------------------
Name: Xxxx X. Xxxxxx
----------------------------
Title: Chief Operating Officer
----------------------------
/s/ Xxxxxxxx X. Xxxxxx
-----------------------------------
XXXXXXXX X. XXXXXX
11
